Sphingolipidosis is a group of inherited metabolic disorders caused by the accumulation of sphingolipids, a type of fat molecule, in the body's cells. This occurs due to deficiencies in specific enzymes that break down these lipids, leading to various health issues. Common types include Tay-Sachs disease, Gaucher disease, and Fabry disease. Symptoms of sphingolipidosis can vary widely but often include neurological problems, organ enlargement, and skin issues. Early diagnosis and management are crucial, as these conditions can lead to severe complications and reduced quality of life. Treatment options may include enzyme replacement therapy and supportive care.